{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:39:57Z","timestamp":1784241597880,"version":"3.55.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Total thyroidectomy (TT) remains the standard surgical treatment of sporadic medullary thyroid cancer (sMTC), primarily due to the presumed risk of occult contralateral disease. However, recent evidence suggests that in selected patients, hemithyroidectomy (HT) may offer comparable oncologic outcomes. This retrospective study aimed to evaluate the prevalence of occult contralateral disease and to identify clinicopathological factors associated with disease-free survival (DFS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed all surgical patients with sMTC at a tertiary academic center (2013\u20132025), excluding patients with hereditary MTC, RET mutations, or clinical evidence of MEN2. Kaplan-Meier analysis with logrank testing was used to identify predictors of DFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Forty-eight patients were included (66.7% female, median age 60.5 years). TT was performed in 44 patients (91.7%). Bilateral disease was present in five patients (11.4%), all detected on preoperative ultrasound. No cases of occult contralateral disease were found. During a median follow-up of 3.4 years, seven patients (14.6%) experienced recurrence. Advanced T stage, nodal involvement, distant metastases, lymphatic and vascular invasion, extracapsular extension, and male sex were all significantly associated with reduced DFS (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Persistent postoperative calcitonin elevation (&gt;\u20092 pg\/mL) strongly predicted recurrence (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), whereas baseline calcitonin\u2009&gt;\u2009500 pg\/mL did not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Occult contralateral disease in sMTC is rare when high-quality preoperative ultrasound is available. In selected patients with unifocal, node-negative tumors and favorable pathology, HT combined with structured calcitonin monitoring may be an oncologically safe, less morbid alternative. These findings support individualized, risk-adapted surgical strategies in sMTC. Prospective validation is warranted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00405-025-09929-1","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T17:53:36Z","timestamp":1766426016000},"page":"1931-1937","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is hemithyroidectomy enough? Low risk of occult contralateral disease in sporadic medullary thyroid cancer"],"prefix":"10.1007","volume":"283","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8077-8781","authenticated-orcid":false,"given":"Andreas","family":"Sp\u00f6rlein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8385-0785","authenticated-orcid":false,"given":"Christoph","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Burkhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8303-5262","authenticated-orcid":false,"given":"Katharina","family":"Laubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9401-8815","authenticated-orcid":false,"given":"Bernd","family":"J\u00e4nigen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"key":"9929_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F et al (2021) Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol 9:225\u2013234. https:\/\/doi.org\/10.1016\/S2213-8587(21)00027-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"9929_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid cancer: A review. JAMA 331:425\u2013435. https:\/\/doi.org\/10.1001\/jama.2023.26348","journal-title":"JAMA"},{"key":"9929_CR3","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1056\/NEJMra1501993","volume":"375","author":"JA Fagin","year":"2016","unstructured":"Fagin JA, Wells SA (2016) Biologic and clinical perspectives on thyroid cancer. N Engl J Med 375:1054\u20131067. https:\/\/doi.org\/10.1056\/NEJMra1501993","journal-title":"N Engl J Med"},{"key":"9929_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1210\/endrev\/bnad013","volume":"44","author":"ML Gild","year":"2023","unstructured":"Gild ML, Clifton-Bligh RJ, Wirth LJ, Robinson BG (2023) Medullary thyroid cancer: updates and challenges. Endocr Rev 44:934\u2013946. https:\/\/doi.org\/10.1210\/endrev\/bnad013","journal-title":"Endocr Rev"},{"key":"9929_CR5","doi-asserted-by":"publisher","unstructured":"Minna E, Romeo P, Dugo M et al (2022) Medullary thyroid carcinoma mutational spectrum update and signaling-type inference by transcriptional profiles: literature meta-analysis and study of tumor samples. Cancers 14:1951. https:\/\/doi.org\/10.3390\/cancers14081951","DOI":"10.3390\/cancers14081951"},{"key":"9929_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","volume":"79","author":"JS Mathiesen","year":"2022","unstructured":"Mathiesen JS, Effraimidis G, Rossing M et al (2022) Multiple endocrine neoplasia type 2: A review. Semin Cancer Biol 79:163\u2013179. https:\/\/doi.org\/10.1016\/j.semcancer.2021.03.035","journal-title":"Semin Cancer Biol"},{"key":"9929_CR7","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.3390\/cancers14153643","volume":"14","author":"K Kaliszewski","year":"2022","unstructured":"Kaliszewski K, Ludwig M, Ludwig B et al (2022) Update on the diagnosis and management of medullary thyroid cancer: what has changed in recent years? Cancers 14:3643. https:\/\/doi.org\/10.3390\/cancers14153643","journal-title":"Cancers"},{"key":"9929_CR8","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1089\/thy.2014.0335","volume":"25","author":"SA Wells","year":"2015","unstructured":"Wells SA, Asa SL, Dralle H et al (2015) Revised American thyroid association guidelines for the management of medullary thyroid carcinoma: the American thyroid association guidelines task force on medullary thyroid carcinoma. Thyroid 25:567\u2013610. https:\/\/doi.org\/10.1089\/thy.2014.0335","journal-title":"Thyroid"},{"key":"9929_CR9","volume-title":"NCCN clinical practice guidelines in oncology (NCCN guidelines): thyroid carcinoma","author":"National Comprehensive Cancer Network","year":"2025","unstructured":"National Comprehensive Cancer Network (2025) NCCN clinical practice guidelines in oncology (NCCN guidelines): thyroid carcinoma. National Comprehensive Cancer Network, Fort Washington, PA"},{"key":"9929_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12515","volume":"81","author":"P Perros","year":"2014","unstructured":"Perros P, Boelaert K, Colley S et al (2014) Guidelines for the management of thyroid cancer. Clin Endocrinol (Oxf) 81:1\u2013122. https:\/\/doi.org\/10.1111\/cen.12515","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9929_CR11","volume-title":"S3 leitlinie Schilddr\u00fcsenkarzinom 2025","author":"D Krebshilfe","year":"2025","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Krebshilfe D, AWMF) (2025) S3 leitlinie Schilddr\u00fcsenkarzinom 2025. Leitlinienprogramm Onkologie, Berlin"},{"key":"9929_CR12","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","volume":"30","author":"S Filetti","year":"2019","unstructured":"Filetti S, Durante C, Hartl D et al (2019) Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 30:1856\u20131883. https:\/\/doi.org\/10.1093\/annonc\/mdz400","journal-title":"Ann Oncol"},{"key":"9929_CR13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/cen.15041","volume":"100","author":"O Cohen","year":"2024","unstructured":"Cohen O, Tzelnick S, Randolph G et al (2024) Initial surgical management of sporadic medullary thyroid cancer: guidelines based optimal care - A systematic review. Clin Endocrinol (Oxf) 100:468\u2013476. https:\/\/doi.org\/10.1111\/cen.15041","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9929_CR14","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1507\/endocrj.EJ20-0025","volume":"67","author":"Y Ito","year":"2020","unstructured":"Ito Y, Onoda N, Okamoto T (2020) The revised clinical practice guidelines on the management of thyroid tumors by the Japan associations of endocrine surgeons: core questions and recommendations for treatments of thyroid cancer. Endocr J 67:669\u2013717. https:\/\/doi.org\/10.1507\/endocrj.EJ20-0025","journal-title":"Endocr J"},{"key":"9929_CR15","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1007\/s00268-002-6665-1","volume":"26","author":"A Miyauchi","year":"2002","unstructured":"Miyauchi A, Matsuzuka F, Hirai K et al (2002) Prospective trial of unilateral surgery for nonhereditary medullary thyroid carcinoma in patients without germline RET mutations. World J Surg 26:1023\u20131028. https:\/\/doi.org\/10.1007\/s00268-002-6665-1","journal-title":"World J Surg"},{"key":"9929_CR16","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/jcm10030543","volume":"10","author":"A Sitges-Serra","year":"2021","unstructured":"Sitges-Serra A (2021) Etiology and diagnosis of permanent hypoparathyroidism after total thyroidectomy. J Clin Med 10:543. https:\/\/doi.org\/10.3390\/jcm10030543","journal-title":"J Clin Med"},{"key":"9929_CR17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/MOO.0000000000000346","volume":"25","author":"RA Dedivitis","year":"2017","unstructured":"Dedivitis RA, Aires FT, Cernea CR (2017) Hypoparathyroidism after thyroidectomy: prevention, assessment and management. Curr Opin Otolaryngol Head Neck Surg 25:142\u2013146. https:\/\/doi.org\/10.1097\/MOO.0000000000000346","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"9929_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jamaoto.2022.0621","volume":"148","author":"V Hsiao","year":"2022","unstructured":"Hsiao V, Light TJ, Adil AA et al (2022) Complication rates of total thyroidectomy vs hemithyroidectomy for treatment of papillary thyroid microcarcinoma: A systematic review and Meta-analysis. JAMA Otolaryngol Neck Surg 148:531. https:\/\/doi.org\/10.1001\/jamaoto.2022.0621","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"9929_CR19","doi-asserted-by":"publisher","unstructured":"Shi M, Nong D, Xin M, Lin L (2022) Accuracy of ultrasound diagnosis of benign and malignant thyroid nodules: a systematic review and meta-analysis. Int J Clin Pract 2022:5056082. https:\/\/doi.org\/10.1155\/2022\/5056082","DOI":"10.1155\/2022\/5056082"},{"key":"9929_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12020-023-03326-6","volume":"81","author":"P Trimboli","year":"2023","unstructured":"Trimboli P, Mian C, Piccardo A, Treglia G (2023) Diagnostic tests for medullary thyroid carcinoma: an umbrella review. Endocrine 81:183\u2013193. https:\/\/doi.org\/10.1007\/s12020-023-03326-6","journal-title":"Endocrine"},{"key":"9929_CR21","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1007\/s00423-022-02591-9","volume":"407","author":"J Zhang","year":"2022","unstructured":"Zhang J, Gu P, Huang D et al (2022) Surgical selection and prognostic analysis in patients with unilateral sporadic medullary thyroid carcinoma. Langenbecks Arch Surg 407:3013\u20133023. https:\/\/doi.org\/10.1007\/s00423-022-02591-9","journal-title":"Langenbecks Arch Surg"},{"key":"9929_CR22","doi-asserted-by":"publisher","first-page":"15663","DOI":"10.1038\/s41598-023-42907-3","volume":"13","author":"H Park","year":"2023","unstructured":"Park H, Ryu HJ, Heo J et al (2023) Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy. Sci Rep 13:15663. https:\/\/doi.org\/10.1038\/s41598-023-42907-3","journal-title":"Sci Rep"},{"key":"9929_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.6004\/jnccn.2024.7088","volume":"23","author":"X Shi","year":"2025","unstructured":"Shi X, Shen C, Liu C et al (2025) Hemithyroidectomy versus total thyroidectomy for sporadic medullary thyroid cancer: A Chinese nationwide Large-Scale cohort study. J Natl Compr Canc Netw 23:105\u2013112. https:\/\/doi.org\/10.6004\/jnccn.2024.7088","journal-title":"J Natl Compr Canc Netw"},{"key":"9929_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.3390\/cancers16050917","volume":"16","author":"A Machens","year":"2024","unstructured":"Machens A, Lorenz K, Brandenburg T et al (2024) Latest progress in Risk-Adapted surgery for medullary thyroid cancer. Cancers 16:917. https:\/\/doi.org\/10.3390\/cancers16050917","journal-title":"Cancers"},{"key":"9929_CR25","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.surg.2023.09.003","volume":"174","author":"H Dralle","year":"2023","unstructured":"Dralle H, Brandenburg T, Weber F et al (2023) Sporadic noninvasive medullary thyroid neoplasm: A desmoplasia-negative unifocal nonmetastatic tumor cured by hemithyroidectomy. Surgery 174:1356\u20131362. https:\/\/doi.org\/10.1016\/j.surg.2023.09.003","journal-title":"Surgery"},{"key":"9929_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.2147\/TCRM.S415860","volume":"19","author":"\u00d6P Horv\u00e1th","year":"2023","unstructured":"Horv\u00e1th \u00d6P, Bellyei S, Pozsgai \u00c9, Vereczkei A (2023) Changes in oncological surgical principles driven by advances in preoperative treatments. Ther Clin Risk Manag Volume 19:667\u2013674. https:\/\/doi.org\/10.2147\/TCRM.S415860","journal-title":"Ther Clin Risk Manag Volume"},{"key":"9929_CR27","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1089\/thy.2016.0255","volume":"26","author":"GF Essig","year":"2016","unstructured":"Essig GF, Porter K, Schneider D et al (2016) Multifocality in sporadic medullary thyroid carcinoma: an international multicenter study. Thyroid 26:1563\u20131572. https:\/\/doi.org\/10.1089\/thy.2016.0255","journal-title":"Thyroid"},{"key":"9929_CR28","unstructured":"Virginia C, Antonio M, Valeria B et al (2025) Multifocality and bilaterality in medullary thyroid cancer. Proof-of-Concept for the Safety of Lobectomy"},{"key":"9929_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/jamaoto.2023.4376","volume":"150","author":"YV Mao","year":"2024","unstructured":"Mao YV, Hughes EG, Steinmetz D et al (2024) Extent of surgery for medullary thyroid cancer and prevalence of occult contralateral foci. JAMA Otolaryngol Neck Surg 150:209\u2013214. https:\/\/doi.org\/10.1001\/jamaoto.2023.4376","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"9929_CR30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1089\/thy.2020.0167","volume":"31","author":"A Kotwal","year":"2021","unstructured":"Kotwal A, Erickson D, Geske JR et al (2021) Predicting outcomes in sporadic and hereditary medullary thyroid carcinoma over two decades. Thyroid Off J Am Thyroid Assoc 31:616\u2013626. https:\/\/doi.org\/10.1089\/thy.2020.0167","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"9929_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.medcli.2011.07.021","volume":"139","author":"A R\u00edos","year":"2012","unstructured":"R\u00edos A, Rodr\u00edguez JM, Febrero B et al (2012) [Prognostic value of clinical, histopathological and immunohistochemical features in medullary thyroid cancer]. Med Clin (Barc) 139:277\u2013283. https:\/\/doi.org\/10.1016\/j.medcli.2011.07.021","journal-title":"Med Clin (Barc)"},{"key":"9929_CR32","doi-asserted-by":"publisher","first-page":"100244","DOI":"10.1016\/j.modpat.2023.100244","volume":"36","author":"F Torricelli","year":"2023","unstructured":"Torricelli F, Santandrea G, Botti C et al (2023) Medullary thyroid carcinomas classified according to the international medullary carcinoma grading system and a Surveillance, Epidemiology, and end Results-Based metastatic risk score: A correlation with genetic profile and angioinvasion. Mod Pathol Off J U S Can Acad Pathol Inc 36:100244. https:\/\/doi.org\/10.1016\/j.modpat.2023.100244","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"9929_CR33","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1055\/a-1559-3424","volume":"53","author":"A Machens","year":"2021","unstructured":"Machens A, Lorenz K, Weber F, Dralle H (2021) Metastatic risk profile of microscopic lymphatic and venous invasion in medullary thyroid cancer. Horm Metab Res Horm Stoffwechselforschung Horm Metab 53:588\u2013593. https:\/\/doi.org\/10.1055\/a-1559-3424","journal-title":"Horm Metab Res Horm Stoffwechselforschung Horm Metab"},{"key":"9929_CR34","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1245\/s10434-010-1021-4","volume":"17","author":"A R\u00edos","year":"2010","unstructured":"R\u00edos A, Rodr\u00edguez JM, Acosta JM et al (2010) Prognostic value of histological and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma. Ann Surg Oncol 17:2444\u20132451. https:\/\/doi.org\/10.1245\/s10434-010-1021-4","journal-title":"Ann Surg Oncol"},{"key":"9929_CR35","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1002\/jso.24070","volume":"112","author":"N Veronese","year":"2015","unstructured":"Veronese N, Luchini C, Nottegar A et al (2015) Prognostic impact of extra-nodal extension in thyroid cancer: A meta\u2010analysis. J Surg Oncol 112:828\u2013833. https:\/\/doi.org\/10.1002\/jso.24070","journal-title":"J Surg Oncol"},{"key":"9929_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.ejso.2014.10.049","volume":"41","author":"A Machens","year":"2015","unstructured":"Machens A, Dralle H (2015) Breach of the thyroid capsule and lymph node capsule in node-positive papillary and medullary thyroid cancer: different biology. Eur J Surg Oncol 41:766\u2013772. https:\/\/doi.org\/10.1016\/j.ejso.2014.10.049","journal-title":"Eur J Surg Oncol"},{"key":"9929_CR37","doi-asserted-by":"publisher","first-page":"1120799","DOI":"10.3389\/fonc.2023.1120799","volume":"13","author":"C Sparano","year":"2023","unstructured":"Sparano C, Adornato V, Puccioni M et al (2023) Early calcitonin levels in medullary thyroid carcinoma: prognostic role in patients without distant metastases at diagnosis. Front Oncol 13:1120799. https:\/\/doi.org\/10.3389\/fonc.2023.1120799","journal-title":"Front Oncol"},{"key":"9929_CR38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1089\/thy.2022.0295","volume":"33","author":"MAdaS Duval","year":"2023","unstructured":"Duval MAdaS, Ferreira CV, Marmitt L et al (2023) An undetectable postoperative calcitonin level is associated with Long-Term Disease-Free survival in medullary thyroid carcinoma: results of a retrospective cohort study. Thyroid Off J Am Thyroid Assoc 33:82\u201390. https:\/\/doi.org\/10.1089\/thy.2022.0295","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"9929_CR39","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1093\/bjs\/znab106","volume":"108","author":"F Fanget","year":"2021","unstructured":"Fanget F, Demarchi MS, Maillard L et al (2021) Medullary thyroid cancer outcomes in patients with undetectable versus normalized postoperative calcitonin levels. Br J Surg 108:1064\u20131071. https:\/\/doi.org\/10.1093\/bjs\/znab106","journal-title":"Br J Surg"},{"key":"9929_CR40","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s00405-023-08249-6","volume":"281","author":"X Lin","year":"2024","unstructured":"Lin X, Huo J, Su H et al (2024) Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol 281:547\u2013561. https:\/\/doi.org\/10.1007\/s00405-023-08249-6","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"9929_CR41","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1001\/jamasurg.2021.6442","volume":"157","author":"W Chen","year":"2022","unstructured":"Chen W, Li J, Peng S et al (2022) Association of total thyroidectomy or thyroid lobectomy with the quality of life in patients with differentiated thyroid cancer with low to intermediate risk of recurrence. JAMA Surg 157:200\u2013209. https:\/\/doi.org\/10.1001\/jamasurg.2021.6442","journal-title":"JAMA Surg"},{"key":"9929_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1089\/thy.2023.0328","volume":"34","author":"K Bach","year":"2024","unstructured":"Bach K, Ansari P, Ansari H et al (2024) Health-Related quality of life in patients with Low-Risk differentiated thyroid cancer: A systematic review examining the extent of thyroidectomy. Thyroid Off J Am Thyroid Assoc 34:14\u201325. https:\/\/doi.org\/10.1089\/thy.2023.0328","journal-title":"Thyroid Off J Am Thyroid Assoc"},{"key":"9929_CR43","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.surg.2019.04.060","volume":"167","author":"PJ Bongers","year":"2020","unstructured":"Bongers PJ, Greenberg CA, Hsiao R et al (2020) Differences in long-term quality of life between hemithyroidectomy and total thyroidectomy in patients treated for low-risk differentiated thyroid carcinoma. Surgery 167:94\u2013101. https:\/\/doi.org\/10.1016\/j.surg.2019.04.060","journal-title":"Surgery"},{"key":"9929_CR44","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1001\/jamaoto.2018.3870","volume":"145","author":"B Nickel","year":"2019","unstructured":"Nickel B, Tan T, Cvejic E et al (2019) Health-Related quality of life after diagnosis and treatment of differentiated thyroid cancer and association with type of surgical treatment. JAMA Otolaryngol Neck Surg 145:231\u2013238. https:\/\/doi.org\/10.1001\/jamaoto.2018.3870","journal-title":"JAMA Otolaryngol Neck Surg"},{"key":"9929_CR45","doi-asserted-by":"publisher","first-page":"14432","DOI":"10.1038\/s41598-025-99191-6","volume":"15","author":"B Wojtczak","year":"2025","unstructured":"Wojtczak B, S\u0119pek M, Sutkowski K et al (2025) Changes in thyroid surgery over last 25 years. Sci Rep 15:14432. https:\/\/doi.org\/10.1038\/s41598-025-99191-6","journal-title":"Sci Rep"},{"key":"9929_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1002\/ohn.481","volume":"170","author":"SPJ van Dijk","year":"2024","unstructured":"van Dijk SPJ, Coerts HI, Lon\u010dar I et al (2024) Regional collaboration and trends in clinical management of thyroid cancer. Otolaryngol\u2013Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg 170:159\u2013168. https:\/\/doi.org\/10.1002\/ohn.481","journal-title":"Otolaryngol\u2013Head Neck Surg Off J Am Acad Otolaryngol-Head Neck Surg"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-025-09929-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-025-09929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:51:46Z","timestamp":1773971506000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-025-09929-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["9929"],"URL":"https:\/\/doi.org\/10.1007\/s00405-025-09929-1","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki and was approved by the local institutional ethics committee (approval number: 24-1592-S1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study was registered in the German Clinical Trials Register (DRKS00037605).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}